Carisma Therapeutics Inc. Stock
Our community identified positive and negative aspects for Carisma Therapeutics Inc. stock for the coming years. 1 users see the criterium "EBIT growth" as a plus for the Carisma Therapeutics Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Carisma Therapeutics Inc. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Carisma Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Carisma Therapeutics Inc. | - | - | - | - | - | - | - |
| Heron Therapeutics Inc. | 0.770% | 4.787% | -31.800% | -66.034% | -38.106% | -50.644% | -94.659% |
| Evolus Inc | -1.160% | -11.458% | -6.077% | -68.807% | -37.615% | -55.844% | -65.313% |
| Sangamo Therapeutics Inc. | -22.980% | -30.535% | -41.893% | -64.349% | -38.736% | -86.757% | -97.993% |